Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Toxicity, Transparency & Sunscreen Regs Among Top “Rose Sheet” Topics In 2011

Executive Summary

“The Rose Sheet” analyzes the stories that garnered the most reader interest and had the highest impact on the personal-care industry in 2011. The top topics include Johnson & Johnson’s reformulation of its baby-care products and the establishment of the Safe Cosmetics Alliance.

Advertisement

Related Content

New CEO Busiek Aims To Grow ICMAD’s Presence, Utility To Members
J&J Plans Baby Shampoo Reformulation; CSC Claims “Victory”
Spray Sunscreens Are Safe, Trade Groups Say; New Test Methods Not Needed
New Industry Alliance Aims To Drum Up Public Support, Emphasizing Safety
FDA Should Grant Labeling Leeway For Cosmetics With SPF, Council Says
Safe Cosmetics Act Would Remedy “Broken Regulatory System,” Says CFSC
FDA Strengthens Sunscreen Testing And Label Requirements
FDA Takes “Property”-Based Approach To Nanotech, Raises Roof To 1 Micron
FDA’s Warning To Lash-Growth Firm Shows Risks In Third-Party Claims
FDA Warns JabaLabs About Drug Claims For Anti-Aging Cosmetics

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

RS017909

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel